<html>
<head>
<meta http-equiv="content-type" content="text/html; charset=utf-8">
</head>
<body text="#000000" bgcolor="#FFFFFF">
<p><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">Dear
Colleagues,</span><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US"><span
style="mso-spacerun:yes"> </span></span> </p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><b style="mso-bidi-font-weight:normal"><span
style="font-size:10.5pt;font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman";mso-bidi-font-family:"Times New
Roman";color:#333333;
background:white;mso-ansi-language:EN-US;mso-fareast-language:PL"
lang="EN-US">Project “CONTRA – Computational Oncology Training
Alliance”</span></b><span
style="font-size:10.5pt;font-family:"Roboto",serif;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:"Times New
Roman";color:#333333;
background:white;mso-ansi-language:EN-US;mso-fareast-language:PL"
lang="EN-US"> for Marie Skłodowska-Curie European Training
Network - <b style="mso-bidi-font-weight: normal">invites 15
PhD students to cooperation</b> – in the field of <b
style="mso-bidi-font-weight:normal">CANCER GENOMIC EVOLUTION</b></span><span
style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US"> </span>
</p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US"><a
href="https://itn-contra.org"><span
style="color:#333333;text-decoration:none;
text-underline:none">https://itn-contra.org</span></a></span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><b style="mso-bidi-font-weight:normal"><span
style="font-size:10.5pt;font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman";mso-bidi-font-family:"Times New
Roman";color:#333333;
background:white;mso-ansi-language:EN-US;mso-fareast-language:PL"
lang="EN-US">Application deadline: 23:59 CET on the 15
February 2018 </span></b></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">CONTRA
(<a href="https://itn-contra.org"><span
style="color:#333333;text-decoration:none;
text-underline:none">https://itn-contra.org</span></a>) is a
H2020 Marie-Sklodowska-Curie Innovative Training Network aimed
at providing a structured training programme to 15 Early Stage
Researchers (ESRs) <b style="mso-bidi-font-weight:normal">to
study tumor evolution using computational techniques</b> upon
novel experimental data including, but not limited to,
single-cell genomic data. See the list of projects at the end of
this message.</span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">The
training structure of CONTRA will include local and network-wide
activities and secondments to other labs in the network. <b
style="mso-bidi-font-weight:normal">Most positions are for 3
years and some for 4 years</b>, contracts starting
approximately July 1, 2018, but all of them lead to a PhD
degree. Specific conditions may apply to individual positions
depending on local regulations. Top-level graduates (master
degree or equivalent) in bioinformatics, statistics,
mathematics, computer science or evolutionary biology are
encouraged to apply. No discrimination will be made on the basis
of nationality, gender, race, religion or disability. </span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">H2020
EU funding imposes strict eligibility criteria. At the time of
recruitment the researcher must not have resided or carried out
his/her main activity (work, studies, etc…) in the country of
the host institute for more than 12 months in the three years
immediately prior to his/her recruitment. The researcher should
also be in the first four years of their research careers at the
time of recruitment by the host organisation and have not been
awarded a doctoral degree. The successful candidate will receive
a very generous financial package. The exact conditions varies
across the universities, but the gross amounts of <b
style="mso-bidi-font-weight: normal">EU funding for an ESR is
in the range 3710€-4210€.</b> The net salary will result from
deducting all compulsory (employer/employee) social security
contributions as well as direct taxes from the gross amounts,
according to the law applicable to the agreement concluded with
the ESR. Some universities will also supplement the EU funding.
EU Guide for applicants: <a href="https://goo.gl/d6LtsE"><span
style="color:#333333;mso-ansi-language:
PL;text-decoration:none;text-underline:none" lang="PL">https://goo.gl/d6LtsE</span></a></span><span
style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US"> </span>
</p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">Candidates
may apply for the positions through the KTH application system <a
href="https://kth.mynetworkglobal.com/en/what:login/jobID:180427/type:job/where:4/apply:1/?_ga=2.89455187.95395237.1513669296-1141512965.1460467751"><span
style="mso-field-code:" HYPERLINK
\0022https\:\/\/goo\.gl\/yTThgg\0022 ""><span
style="color:#333333;mso-ansi-language:PL;text-decoration:none;
text-underline:none" lang="PL">https://goo.gl/yTThgg</span></span></a></span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><b style="mso-bidi-font-weight:normal"><span
style="font-size:10.5pt;font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman";mso-bidi-font-family:"Times New
Roman";color:#333333;
background:white;mso-ansi-language:EN-US;mso-fareast-language:PL"
lang="EN-US">The application should include the following
documents: </span></b></p>
<p class="MsoListParagraphCxSpFirst"
style="margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-align:justify;text-indent:-18.0pt;line-height:normal;
mso-list:l0 level1 lfo1"> </p>
<p class="MsoListParagraphCxSpFirst"
style="margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-align:justify;text-indent:-18.0pt;line-height:normal;
mso-list:l0 level1 lfo1"><span
style="font-size:10.5pt;font-family:"Roboto",serif;mso-fareast-font-family:Roboto;mso-bidi-font-family:Roboto;color:#333333;mso-ansi-language:EN-US;
mso-fareast-language:PL" lang="EN-US"><span
style="mso-list:Ignore">1.<span style="font:7.0pt "Times
New Roman""> </span></span></span><span
style="font-size:10.5pt;font-family:"Roboto",serif;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:"Times New
Roman";color:#333333;
background:white;mso-ansi-language:EN-US;mso-fareast-language:PL"
lang="EN-US">1. Curriculum vitae with at most 3 pages</span></p>
<p class="MsoListParagraphCxSpMiddle"
style="margin-bottom:0cm;margin-bottom:
.0001pt;mso-add-space:auto;text-align:justify;text-indent:-18.0pt;line-height:
normal;mso-list:l0 level1 lfo1"><span
style="font-size:10.5pt;font-family:"Roboto",serif;mso-fareast-font-family:Roboto;mso-bidi-font-family:Roboto;color:#333333;mso-ansi-language:EN-US;
mso-fareast-language:PL" lang="EN-US"><span
style="mso-list:Ignore">2.<span style="font:7.0pt "Times
New Roman""> </span></span></span><span
style="font-size:10.5pt;font-family:"Roboto",serif;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:"Times New
Roman";color:#333333;
background:white;mso-ansi-language:EN-US;mso-fareast-language:PL"
lang="EN-US">2. Transcripts from University / University College</span></p>
<p class="MsoListParagraphCxSpMiddle"
style="margin-bottom:0cm;margin-bottom:
.0001pt;mso-add-space:auto;text-align:justify;text-indent:-18.0pt;line-height:
normal;mso-list:l0 level1 lfo1"><span
style="font-size:10.5pt;font-family:"Roboto",serif;mso-fareast-font-family:Roboto;mso-bidi-font-family:Roboto;color:#333333;mso-ansi-language:EN-US;
mso-fareast-language:PL" lang="EN-US"><span
style="mso-list:Ignore">3.<span style="font:7.0pt "Times
New Roman""> </span></span></span><span
style="font-size:10.5pt;font-family:"Roboto",serif;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:"Times New
Roman";color:#333333;
background:white;mso-ansi-language:EN-US;mso-fareast-language:PL"
lang="EN-US">3. Contact details for three references</span></p>
<p class="MsoListParagraphCxSpMiddle"
style="margin-bottom:0cm;margin-bottom:
.0001pt;mso-add-space:auto;text-align:justify;text-indent:-18.0pt;line-height:
normal;mso-list:l0 level1 lfo1"><span
style="font-size:10.5pt;font-family:"Roboto",serif;mso-fareast-font-family:Roboto;mso-bidi-font-family:Roboto;color:#333333;mso-ansi-language:EN-US;
mso-fareast-language:PL" lang="EN-US"><span
style="mso-list:Ignore">4.<span style="font:7.0pt "Times
New Roman""> </span></span></span><span
style="font-size:10.5pt;font-family:"Roboto",serif;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:"Times New
Roman";color:#333333;
background:white;mso-ansi-language:EN-US;mso-fareast-language:PL"
lang="EN-US">4. Brief description of why the applicant wishes to
become a PhD student within this network</span></p>
<p class="MsoListParagraphCxSpLast"
style="margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-align:justify;text-indent:-18.0pt;line-height:normal;
mso-list:l0 level1 lfo1"><span
style="font-size:10.5pt;font-family:"Roboto",serif;mso-fareast-font-family:Roboto;mso-bidi-font-family:Roboto;color:#333333;mso-ansi-language:EN-US;
mso-fareast-language:PL" lang="EN-US"><span
style="mso-list:Ignore">5.<span style="font:7.0pt "Times
New Roman""> </span></span></span><span
style="font-size:10.5pt;font-family:"Roboto",serif;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:"Times New
Roman";color:#333333;
background:white;mso-ansi-language:EN-US;mso-fareast-language:PL"
lang="EN-US">5. Ranking of 3 ESR projects based on the
applicant’s preference</span></p>
<p> </p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">Each
project supervisor will revise the candidates’ documentation
and, on the basis of the completeness and adequacy of the
requested material and eligibility, will score candidates based
on: (1) academic profile; (2) personal motivation; (3)
scientific skills and relevant experience; and (4) English
proficiency. Shortlisted candidates will be invited to
teleconference interviews with the relevant project
supervisor(s). </span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">Application
deadline: 23:59 CET on 15 February 2018. Candidates are invited
to contact the supervisors for more details. For individual
descriptions of the 15 projects, please use the following link:
<a href="https://itn-contra.org/esr-projects/"><span
style="color:#333333;text-decoration:none;text-underline:none">https://itn-contra.org/esr-projects/</span></a>.
</span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><b style="mso-bidi-font-weight:normal"><span
style="font-size:10.5pt;font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman";mso-bidi-font-family:"Times New
Roman";color:#333333;
background:white;mso-ansi-language:EN-US;mso-fareast-language:PL"
lang="EN-US">List of projects, including supervisor and host
institution:</span></b><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US"> </span>
</p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">-
<b style="mso-bidi-font-weight: normal">ESR1</b>: Comparing
tumour phylogenies from single cell data versus bulk sequencing
data. Florian Markowetz, University of Cambridge, Cambridge, UK.</span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">-
<b style="mso-bidi-font-weight: normal">ESR2</b>: The mechanisms
of coding and non-coding oncogenic alterations. Nuria
Lopez-Bigas, IRB, Barcelona, Spain.</span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">-
<b style="mso-bidi-font-weight: normal">ESR3</b>: Identification
of drivers of relapse and metastasis. Nuria Lopez-Bigas, IRB,
Barcelona, Spain.</span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">-
<b style="mso-bidi-font-weight: normal">ESR4:</b> Estimating
tumour phylogenies from single-cell SNV and CNA data. Niko
Beerenwinkel, ETH Zurich, Basel, Switzerland.</span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">-
<b style="mso-bidi-font-weight: normal">ESR5</b>: Evolutionary
history of circulating tumour cells and distant metastases. Ewa
Szczurek, University of Warsaw, Warsaw, Poland.</span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">-
<b style="mso-bidi-font-weight: normal">ESR6</b>: Identification
and impact of clonal and subclonal driver alterations on cancer
progression. Francesca Ciccarelli, KCL/Crick Institute, London,
UK.</span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">-
<b style="mso-bidi-font-weight: normal">ESR7</b>: Inferring
tumour evolution and migration. Niko Beerenwinkel, ETH Zurich,
Basel, Switzerland.</span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">-
<b style="mso-bidi-font-weight: normal">ESR8</b>: Models and
inference for Single-cell sequencing and tumour evolution. Jens
Lagergren, KTH, Stockholm, Sweden.</span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">-
<b style="mso-bidi-font-weight: normal">ESR9</b>: Evolution of
drug resistance on genetic and phenotypic levels. Ewa Szczurek,
University of Warsaw, Warsaw, Poland.</span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">-
<b style="mso-bidi-font-weight: normal">ESR10</b>: Driver
events, evolutionary dynamics and interplay with the external
environment across cancer types. Francesca Ciccarelli, KCL/Crick
Institute, London, UK.</span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">-
<b style="mso-bidi-font-weight: normal">ESR11</b>: Estimation of
tumour growth rates from NGS data. David Posada, University of
Vigo, Vigo, Spain.</span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">-
<b style="mso-bidi-font-weight: normal">ESR12</b>: Mutational
patterns and models within tumours. David Posada, University of
Vigo, Vigo, Spain.</span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">-
<b style="mso-bidi-font-weight: normal">ESR13</b>: Integrated
image and genomics. Yinyin Yuan, ICR, London, UK.</span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">-
<b style="mso-bidi-font-weight: normal">ESR14</b>: Spatial
genetics and transcriptomics of pancreatic and ovarian cancer.
Florian Markowetz, University of Cambridge, Cambridge, UK.</span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">-
<b style="mso-bidi-font-weight: normal">ESR15</b>: Reconciling
tumour trees and multiple tumour progression models. Jens
Lagergren, KTH, Stockholm, Sweden.</span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US"> </span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">Please
forward this message to possible candidates in your network.</span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US"> </span></p>
<p class="MsoNormal"
style="margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal"><span style="font-size:10.5pt;
font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman"; mso-bidi-font-family:"Times New
Roman";color:#333333;background:white;
mso-ansi-language:EN-US;mso-fareast-language:PL" lang="EN-US">Best
regards,</span></p>
<span
style="font-size:10.5pt;line-height:107%;font-family:"Roboto",serif;mso-fareast-font-family:"Times
New Roman";mso-bidi-font-family:"Times New Roman";
color:#333333;background:white;mso-ansi-language:EN-US;mso-fareast-language:
PL;mso-bidi-language:AR-SA" lang="EN-US">Iwona Zielińska<br>
</span>
<div class="moz-signature">-- <br>
<p>
Iwona Zielińska<br>
project manager<br>
Horizon 2020 - CONTRA<br>
</p>
<p>
University of Warsaw<br>
<a class="moz-txt-link-abbreviated" href="http://www.uw.edu.pl">www.uw.edu.pl</a><br>
<a class="moz-txt-link-abbreviated" href="http://www.mimuw.edu.pl">www.mimuw.edu.pl</a><br>
</p>
<p>
</p>
</div>
</body>
</html>